M Kaddar

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Global support for new vaccine implementation in middle-income countries
    Miloud Kaddar
    World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Vaccine 31:B81-96. 2013
  2. pmc Financial challenges of immunization: a look at GAVI
    Miloud Kaddar
    Department of Immunization, Vaccines and Biologicals, World Health Organization, CH 1211 Geneva 27, Switzerland
    Bull World Health Organ 82:697-702. 2004
  3. pmc Are current debt relief initiatives an option for scaling up health financing in beneficiary countries?
    M Kaddar
    Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 86:877-83. 2008
  4. pmc The impact of the Global Polio Eradication Initiative on the financing of routine immunization: case studies in Bangladesh, C te d'Ivoire, and Morocco
    Ann Levin
    Family Health International, Washington, DC 20008, USA
    Bull World Health Organ 80:822-8. 2002
  5. pmc The economics of vaccination in low- and middle-income countries
    J A Fox-Rushby
    Bull World Health Organ 82:640. 2004
  6. pmc Managing the effect of TRIPS on availability of priority vaccines
    Julie Milstien
    Center for Vaccine Development, School of Medicine, University of Maryland, Montpellier, France
    Bull World Health Organ 84:360-5. 2006
  7. ncbi request reprint Access to vaccine technologies in developing countries: Brazil and India
    Julie B Milstien
    University of Maryland School of Medicine, 3 bis rue des Coronilles, Résidence Parc de Clementville Bâtiment C, 34070 Montpellier, France
    Vaccine 25:7610-9. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Global support for new vaccine implementation in middle-income countries
    Miloud Kaddar
    World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Vaccine 31:B81-96. 2013
    ..This will require political will, joint planning, and additional modest funding...
  2. pmc Financial challenges of immunization: a look at GAVI
    Miloud Kaddar
    Department of Immunization, Vaccines and Biologicals, World Health Organization, CH 1211 Geneva 27, Switzerland
    Bull World Health Organ 82:697-702. 2004
    ..This article focuses on how GAVI is addressing the challenge of sustaining adequate and reliable funding for immunizations in the poorest countries...
  3. pmc Are current debt relief initiatives an option for scaling up health financing in beneficiary countries?
    M Kaddar
    Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 86:877-83. 2008
    ..There should be careful monitoring of fungibility (i.e. where untraceable funds risk substitution) and additionality (i.e. the extent to which new inputs add to existing inputs at national and international level)...
  4. pmc The impact of the Global Polio Eradication Initiative on the financing of routine immunization: case studies in Bangladesh, C te d'Ivoire, and Morocco
    Ann Levin
    Family Health International, Washington, DC 20008, USA
    Bull World Health Organ 80:822-8. 2002
    ..The results show that the PEI did not reduce funding for routine immunizations in these countries...
  5. pmc The economics of vaccination in low- and middle-income countries
    J A Fox-Rushby
    Bull World Health Organ 82:640. 2004
  6. pmc Managing the effect of TRIPS on availability of priority vaccines
    Julie Milstien
    Center for Vaccine Development, School of Medicine, University of Maryland, Montpellier, France
    Bull World Health Organ 84:360-5. 2006
    ..The role of international organizations in defining best practices, dissemination of information, and monitoring TRIPS impact will be crucial to ensuring optimal access to priority new vaccines for the developing world...
  7. ncbi request reprint Access to vaccine technologies in developing countries: Brazil and India
    Julie B Milstien
    University of Maryland School of Medicine, 3 bis rue des Coronilles, Résidence Parc de Clementville Bâtiment C, 34070 Montpellier, France
    Vaccine 25:7610-9. 2007
    ..A case study on development of a new combination vaccine illustrates these findings...